Dr. Kathrin Dvir, MD

Dr. Dvir practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Dvir's NPI, 1417441163, was assigned on June 17, 2018. Dr. Dvir graduated from St. George's Hospital Medical School in 2016. Dr. Dvir holds Florida license ME165358.

Dr. Dvir's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Dvir also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Dvir's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Dvir to 1 more breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dvir practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dvir's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dvir is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Dvir's licenses on file in 2 states: Florida and Massachusetts.

CMS data shows 15 Medicare services from Dr. Dvir across 1 procedure code in 2024, all of them office visits, for 18 Medicare patients. Medicare paid $1,690 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 18 Medicare patients who saw Dr. Dvir in 2024. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 0.69, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dvir's median patient age at 61, with 99% women.

In 2024, Dr. Dvir wrote 56 Medicare Part D claims for 31 patients. 89% of them were for generic drugs. CMS names the drug for 40 of them, across 2 drugs with 11 or more claims each, at $831 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Dvir accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dvir as offering telehealth.

Dmand AI links 12 papers to Dr. Dvir, published from 2019 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Colonic Neoplasms. Dr. Dvir has published most often in J Investig Med High Impact Case Rep. Dr. Dvir's most frequent co-authors are Michael Alan Schwartz, MD, Kfir Ben-David, MD and Avan Jamshid Armaghani, MD.

CMS Open Payments shows 17 general payments to Dr. Dvir from 9 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 73% of the total. Genentech, Inc. paid the most, $2,187.

Dr. Dvir graduated from St. George's Hospital Medical School in 2016.

Dr. Dvir is in network with 5 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.